What are the recommended antibiotic regimens for acute paronychia?

Antibiotic Recommendations for Acute Paronychia

For uncomplicated acute paronychia, antibiotics are generally not needed if adequate drainage is achieved; however, when antibiotics are indicated, amoxicillin-clavulanate is the empirical agent of choice, covering both Staphylococcus aureus (the most common pathogen) and streptococci.

When to Use Antibiotics

Antibiotics are indicated in the following scenarios:

• Severe infection with systemic signs (fever, lymphangitis, cellulitis extending beyond the nail fold)
• Immunocompromised patients (diabetes, chemotherapy, HIV)
• Failed drainage or inadequate surgical access
• Presence of significant surrounding cellulitis

For simple acute paronychia with successful incision and drainage, oral antibiotics are usually unnecessary 1, 2. Recent evidence from 2025 confirms that postoperative antibiotic therapy does not influence recurrence in uncomplicated cases 3.

Antibiotic Selection Algorithm

First-Line Empirical Therapy

Amoxicillin-clavulanate is the preferred empirical agent:

• Adult dose: 875/125 mg twice daily 4
• Pediatric dose: 25 mg/kg/day (amoxicillin component) in 2 divided doses 4
• Rationale: Covers S. aureus (30% of isolates), streptococci, and oral anaerobes; only 4.7% bacterial resistance documented 3

Alternative Oral Regimens (for penicillin allergy or specific situations)

For non-severe penicillin allergy:

• Cephalexin: 500 mg four times daily (adults) or 25-50 mg/kg/day in 4 divided doses (children) 4

For severe penicillin allergy or MRSA risk factors:

• Clindamycin: 300-450 mg four times daily (adults) or 30-40 mg/kg/day in 3 divided doses (children) 4
• Trimethoprim-sulfamethoxazole: 1-2 double-strength tablets twice daily (adults) or 8-12 mg/kg/day based on TMP component in 2 divided doses (children) 4

MRSA Coverage Indications

Consider MRSA-active antibiotics when:

• Penetrating trauma history
• Known MRSA colonization
• Injection drug use
• Failed initial therapy
• Systemic inflammatory response syndrome (SIRS) present 4

Parenteral Therapy (for severe infections with systemic involvement)

MSSA coverage:

• Nafcillin or oxacillin: 1-2 g every 4 hours IV 4
• Cefazolin: 1 g every 8 hours IV (preferred for convenience and less toxicity) 4

MRSA coverage:

• Vancomycin: 30 mg/kg/day in 2 divided doses IV 4

Duration of Therapy

5 days is the recommended duration, extending only if infection has not improved within this timeframe 4. This aligns with general SSTI guidelines from IDSA.

Critical Pitfalls to Avoid

1. Do not prescribe preoperative antibiotics - they should be avoided in routine cases 3
2. Do not use antibiotics as substitute for drainage - abscess requires surgical intervention first 1, 2
3. Do not obtain routine cultures in simple cases - bacteriological sampling has limited clinical benefit in uncomplicated paronychia 3
4. Do obtain cultures when: immunocompromised, severe infection, treatment failure, or unusual presentation 4

Special Considerations

Chronic paronychia (>6 weeks duration) is primarily an inflammatory/irritant condition, not infectious. Treatment focuses on:

• Avoiding irritants and moisture exposure
• Topical corticosteroids (not antibiotics) as primary therapy 1, 5, 6
• Antifungals only if Candida documented, though evidence shows limited efficacy 6

The key distinction: acute paronychia is infectious and may warrant antibiotics in specific circumstances, while chronic paronychia is inflammatory and responds to corticosteroids with hand-care modifications 6.